| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
MAQUET offers complete medical technology solutions for operating theatres and intensive care units, guaranteeing optimum treatment for patients and greatest-possible working comfort for personnel. MAQUET - The Gold Standard. To enter the MAQUET website
Smart devices and digital support that connect patients to care, with clinically-proven results https://t.co/zoMxznOfwA
Lifeguard International is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Marin General Hospital provides primary and secondary levels of care in addition to Marin Cancer Institute and Haynes Cardiovascular Institute.